MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Phase 2

Active, not recruiting

Conditions: Coronavirus Infections
Pneumonia, Viral
Acute Respiratory Distress Syndrome

Interventions: Drug: Nitric Oxide

First Posted Date: 2020-03-12

Last Posted Date: 2022-11-01

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT04305457

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Louisiana State University Health Shreveport, Shreveport, Louisiana, United States
🇺🇸
Providence HealthCare Network, Anchorage, Alaska, United States

Interprofessional Group Intervention to Promote Faculty Wellbeing and Engagement

Not Applicable

Completed

Conditions: Burnout, Professional

Interventions: Other: Discussion Guide

First Posted Date: 2020-03-12

Last Posted Date: 2020-03-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 25

Registration Number: NCT04305886

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19

Phase 2

Completed

Conditions: Coronavirus
SARS (Severe Acute Respiratory Syndrome)

Interventions: Drug: Nitric Oxide Gas

First Posted Date: 2020-03-12

Last Posted Date: 2022-06-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 200

Registration Number: NCT04306393

Locations: 🇸🇪
Danderyd Sjukhus AB, Danderyd, Stockholm, Sweden
🇺🇸
Louisiana State University Health Shreveport, Shreveport, Louisiana, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 2 locations

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Not Applicable

Recruiting

Conditions: Traumatic Brain Injury
Attention Deficit Hyperactivity Disorder
Bipolar Disorder
Schizophrenia
Borderline Personality Disorder
Substance Use Disorders
Major Depressive Disorder

Interventions: Device: Transcranial Direct Current Stimulation

First Posted Date: 2020-03-05

Last Posted Date: 2024-03-22

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 600

Registration Number: NCT04296604

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Not Applicable

Conditions: Mild Cognitive Impairment
Aging
Alzheimer Disease

Interventions: Device: repetitive transcranial magnetic stimulation (rTMS)

First Posted Date: 2020-03-04

Last Posted Date: 2020-03-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT04294888

Locations: 🇺🇸
Massachuetts General Hospital, Charlestown, Massachusetts, United States

Light Therapy for PD - Dose Selection

Not Applicable

Active, not recruiting

Conditions: Sleep Disorder
Parkinson Disease
Fatigue

Interventions: Device: SunRay Light Boxes

First Posted Date: 2020-03-02

Last Posted Date: 2022-12-14

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 144

Registration Number: NCT04291014

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
Weill Cornell, New York, New York, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

and more 22 locations

Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery

Phase 2

Completed

Conditions: Critical Illness
Acute Respiratory Distress Syndrome
Respiratory Failure
Sepsis

Interventions: Drug: 5% Dextrose (room temperature)
Drug: 5% Dextrose refrigerated
Drug: Intravenous Acetaminophen (room temperature)
Drug: Intravenous Vitamin C (refrigerated)

First Posted Date: 2020-03-02

Last Posted Date: 2023-10-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 488

Registration Number: NCT04291508

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
🇺🇸
Hennepin County Medical Center, Minneapolis, Minnesota, United States

and more 38 locations

Lorlatinib Combinations in Lung Cancer

Phase 1

Conditions: MET Amplification
ROS1 Rearrangement
Lung Cancer
Relapsed Cancer
Anaplastic Lymphoma Kinase Gene Translocation
Resistant Cancer
NSCLC

Interventions: Drug: Lorlatinib
Drug: TNO155
Drug: Crizotinib
Drug: Binimetinib

First Posted Date: 2020-03-02

Last Posted Date: 2021-03-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 96

Registration Number: NCT04292119

Locations: 🇺🇸
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema

Not Applicable

Conditions: High Altitude Pulmonary Edema
Non-Invasive Positive Pressure Ventilation
Hypoxia

Interventions: Device: Non-Invasive Positive Pressure Ventilation
Drug: Nifedipine
Other: supplemental oxygen

First Posted Date: 2020-02-28

Last Posted Date: 2020-09-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 16

Registration Number: NCT04288219

Locations: 🇳🇵
Himalayan Rescue Association, Kathmandu, Nepal

Cortical-Basal Ganglia Speech Networks

Not Applicable

Recruiting

Conditions: Parkinson Disease
Essential Tremor
Dystonia

Interventions: Other: electrophysiological data collection

First Posted Date: 2020-02-27

Last Posted Date: 2024-06-27

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 80

Registration Number: NCT04286308

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy